Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. McCully KS . Homocysteine and vascular disease. Nat Med 1996; 2: 386–389.

    Article  CAS  Google Scholar 

  2. Mudd SH, Levy HL, Skovby F . Disorders of transulfuration. In: Scriver C, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease. McGraw-Hill Book Co,: New York, 1989, pp 693–734.

    Google Scholar 

  3. Stabler SP et al. Elevation of total homocysteine in the serum of patients with cobalamin of folate deficiency detected by capillary gas chromatography–mass spectrometry. J Clin Invest 1998; 81: 466–474.

    Article  Google Scholar 

  4. Frosst P et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113.

    Article  CAS  Google Scholar 

  5. Perry IJ . Homocysteine, hypertension and stroke. J Hum Hypertens 1999; 13: 289–293.

    Article  CAS  Google Scholar 

  6. Reports of the Second Task Force on Blood Pressure Control in Children. National Heart, Lung and Blood Institute, Bethesola, Maryland, 1987. Pediatrics 1987; 79: 1–25.

  7. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [see comments]. JAMA 1995; 274: 1049–1057.

    Article  CAS  Google Scholar 

  8. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L . Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998; 98: 2520–2526.

    Article  CAS  Google Scholar 

  9. Tsai JC et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369–6373.

    Article  CAS  Google Scholar 

  10. El Kossi MM, Zakhary MM . Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000; 31: 1889–1892.

    Article  CAS  Google Scholar 

  11. Kanani PM et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999; 100: 1161–1168.

    Article  CAS  Google Scholar 

  12. Kitiyakara C, Gonin J, Massy Z, Wilcox CS . Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia. Curr Opin Nephrol Hypertens 2000; 9: 477–487.

    Article  CAS  Google Scholar 

  13. Mujumdar VS, Hayden MR, Tyagi SC . Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol 2000; 183: 28–36.

    Article  CAS  Google Scholar 

  14. Kosmala W . [Endothelial dysfunction in hypertension—clinical implications]. Pol Merkuriusz Lek 2002; 12: 333–335.

    Google Scholar 

  15. Groop L . Genetics of the metabolic syndrome. Br J Nutr 2000; 83: S39–S48.

    Article  CAS  Google Scholar 

  16. Genest J . Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114–1119.

    Article  Google Scholar 

  17. Sorensen TK et al. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999; 48: 98–103.

    Article  CAS  Google Scholar 

  18. Yoo JH, Chung CS, Kang SS . Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998; 29: 2478–2483.

    Article  CAS  Google Scholar 

  19. Collaboration HLT . Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316: 894–898.

    Article  Google Scholar 

Download references

Acknowledgements

This work was partially supported by Grants PID 0587 (Agencia Nacional de Promoción Científica y Técnica) and TM65 (Universidad de Buenos Aires) SIG, PIP and CJP belong to CONICET

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C J Pirola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garfunkel, V., Porto, P., Garcia, S. et al. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension. J Hum Hypertens 17, 361–364 (2003). https://doi.org/10.1038/sj.jhh.1001549

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001549

This article is cited by

Search

Quick links